Literature DB >> 25882313

Bioassay-guided isolation and identification of cytotoxic compounds from Bolbostemma paniculatum.

Yun Tang1, Wei Li3, Jiaqing Cao3, Wei Li3, Yuqing Zhao4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Bolbostemma paniculatum (Maxim.) Franquet (B. paniculatum), also named "Tu-bei-mu" in Chinese folk medicines, has been described in application for the treatment of tumors, warts, inflammation and toxication in traditional Chinese medicinal books. The major constituents in B. paniculatum are triterpenoid saponins, which have been proved to possess dramatically cytotoxic activity and antivirus activity. The aim of this study is to isolate and identify the active triterpenoid saponin from the bulb of B. paniculatum by a bioassay-guided method.
MATERIALS AND METHODS: Four cucurbitacine triterpenoid sapogenins and 11 triterpenoid saponins were isolated from the active EtOAc and n-BuOH extract of B. paniculatum by using bioassay-guided screening. Their structures were elucidated based on the spectroscopic methods and compared with published data. Cytotoxic activities of isolated compounds were determined by MTT assay.
RESULTS: Four cucurbitacine triterpenoid sapogenins, isocucurbitacin B(1), 23,24-dihydroisocucurbitacin B(2), cucurbitacin E(3), 23,24-dihydrocucurbitacin E(4), and 11 triterpenoid saponins, tubeimosideI(5), tubeimoside III(6), tubeimoside V(7), dexylosyltubeimoside III(8), lobatoside C(9), tubeimoside A(10), tumeimoside B(11), lobatoside A(12), tubeimoside C(13), tubeimoside IV(14), 7β,18,20,26-tetrahydroxy-(20S)-dammar-24E-en-3-O-α-L-(4-acetyl)arabinopyranosyl-(1→2)-β-D-glucopyranoside(15) were isolated from the active EtOAc and n-BuOH extracts. Of them, compounds 2, 4, 9 and 12 were firstly isolated from the Bolbostemma genus. MTT assay revealed that compounds 1, 3 and 4 had significantly activities against HeLa and HT-29 human cancer cells with IC50 values ranging from 0.93 to 9.73μM. It is worth mentioning that compound 4׳s activities against the two cell lines are 12- and 8-fold that of the positive control drug (5-Fu). Whereas, the cyclic bisdesmosides 5-9 exerted significantly activities on BGC-823, HeLa, HT-29 and MCF-7 cancer cells with IC50 values ranging from 1.30 to 15.64μM. And 6׳s activities against the four cell lines are 6-, 3-, 10- and 16-fold that of 5-Fu and 8׳s activities against the four cell lines are 5-, 3-, 14- and 9-fold that of 5-Fu.
CONCLUSION: The cytotoxic activity of the bulbs of B. paniculatum is mainly ascribable to cucurbitacine triterpenoid sapogenins (1-4) and the cyclic bisdesmosides (5-9). The cyclic bisdesmosides are the main anti-cancer active compounds of B. paniculatum. The above results provide scientific evidence to support, to some extent, the ethnomedicinal use of B. paniculatum as anticancer remedies in traditional Chinese medicine.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bolbostemma paniculatum; Cyclic bisdesmosides; Cytotoxicity; Triterpenoid; Tubeimoside

Mesh:

Substances:

Year:  2015        PMID: 25882313     DOI: 10.1016/j.jep.2015.04.003

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  9 in total

1.  Novel Triterpenoid Alkaloids With Their Potential Cytotoxic Activity From the Roots of Siraitia grosvenorii.

Authors:  Huijuan Wang; Guoxu Ma; Huaxiang Wang; Lingyu Li; Aijun Dong; Huiping Liu; Xiaoshuang Huo; Jianyong Si; Junchi Wang
Journal:  Front Chem       Date:  2022-04-29       Impact factor: 5.545

2.  The Inhibition of Gastric Cancer Cells' Progression by 23,24-Dihydrocucurbitacin E through Disruption of the Ras/Raf/ERK/MMP9 Signaling Pathway.

Authors:  Huiping Liu; Huijuan Wang; Aijun Dong; Xiaoshuang Huo; Huaxiang Wang; Junchi Wang; Jianyong Si
Journal:  Molecules       Date:  2022-04-22       Impact factor: 4.927

3.  Extracts of Physalis peruviana Protect Astrocytic Cells Under Oxidative Stress With Rotenone.

Authors:  Natalia Areiza-Mazo; Jorge Robles; Jairo A Zamudio-Rodriguez; Lisandro Giraldez; Valentina Echeverria; Biviana Barrera-Bailon; Gjumrakch Aliev; Amirhossein Sahebkar; Ghulam Md Ashraf; George E Barreto
Journal:  Front Chem       Date:  2018-07-20       Impact factor: 5.221

4.  Total saponins of Bolbostemma paniculatum (maxim.) Franquet exert antitumor activity against MDA-MB-231 human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway.

Authors:  Jian-Wei Dou; Rong-Guo Shang; Xiao-Qin Lei; Kang-Le Li; Zhan-Zi Guo; Kai Ye; Xiao-Juan Yang; Yu-Wei Li; Yun-Yun Zhou; Jia Yao; Qian Huang
Journal:  BMC Complement Altern Med       Date:  2019-11-08       Impact factor: 3.659

5.  Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.

Authors:  Lan-Lan Wang; Chen Liao; Xiao-Qiang Li; Rong Dai; Qing-Wei Ren; Hai-Long Shi; Xiao-Ping Wang; Xue-Song Feng; Xu Chao
Journal:  Med Sci Monit       Date:  2021-01-13

Review 6.  Chinese endemic medicinal plant Bolbostemma paniculatum (Maxim.) Franquet: A comprehensive review.

Authors:  Yujiao Zhou; Junyu Liu; Jianqiong Zhang; Yi Xu; Wangni Li; Pang Gao; Yanghuan Xing; Lehong Huang; Xuhua Qin; Shenrui Jin
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

Review 7.  A Review of Medicinal Plants of the Himalayas with Anti-Proliferative Activity for the Treatment of Various Cancers.

Authors:  Hailemeleak Regassa; Anuradha Sourirajan; Vikas Kumar; Sadanand Pandey; Deepak Kumar; Kamal Dev
Journal:  Cancers (Basel)       Date:  2022-08-12       Impact factor: 6.575

8.  Rapid Characterization of Components in Bolbostemma paniculatum by UPLC/LTQ-Orbitrap MSn Analysis and Multivariate Statistical Analysis for Herb Discrimination.

Authors:  Yanling Zeng; Yang Lu; Zhao Chen; Jiawei Tan; Jie Bai; Pengyue Li; Zhixin Wang; Shouying Du
Journal:  Molecules       Date:  2018-05-11       Impact factor: 4.411

9.  A novel glucuronosyltransferase has an unprecedented ability to catalyse continuous two-step glucuronosylation of glycyrrhetinic acid to yield glycyrrhizin.

Authors:  Guojie Xu; Wei Cai; Wei Gao; Chunsheng Liu
Journal:  New Phytol       Date:  2016-06-02       Impact factor: 10.151

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.